1 Result(s)

Article

Structure-based classification predicts drug response in EGFR-mutant NSCLC

Epidermal growth factor receptor (EGFR) mutations typically occur in exons 18–21 and are established driver mutations in non-small cell lung cancer (NSCLC)^1–3. Targeted therapies are approved for patients with ‘c...

Jacqulyne P. Robichaux, **uning Le, R. S. K. Vijayan, J. Kevin Hicks, Simon Heeke… in Nature (2021)